Trial Profile
Study of CERC-611 for epilepsy
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 15 Jul 2022
Price :
$35
*
At a glance
- Drugs Cerc 611 (Primary)
- Indications Epilepsy
- Focus Adverse reactions
- 06 Oct 2016 New trial record